BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 29048620)

  • 1. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
    Nowacka-Zawisza M; Wiśnik E
    Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.
    Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Nicoli D; Farnetti E; Santandrea G; Bonacini M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenetics of prostate cancer].
    Yi XM; Zhou WQ
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):635-41. PubMed ID: 20873600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic targets in the diagnosis and treatment of prostate cancer.
    Manoharan M; Ramachandran K; Soloway MS; Singal R
    Int Braz J Urol; 2007; 33(1):11-8. PubMed ID: 17335593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic mechanisms in gastric cancer.
    Gigek CO; Chen ES; Calcagno DQ; Wisnieski F; Burbano RR; Smith MA
    Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.
    Ramzan F; Vickers MH; Mithen RF
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of human retinoblastoma.
    Singh U; Malik MA; Goswami S; Shukla S; Kaur J
    Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in lung cancer diagnosis and therapy.
    Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
    Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
    Ebrahimi V; Soleimanian A; Ebrahimi T; Azargun R; Yazdani P; Eyvazi S; Tarhriz V
    Gene; 2020 Jun; 742():144577. PubMed ID: 32171825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic potentials of dietary polyphenols in prostate cancer management.
    Abbas A; Patterson W; Georgel PT
    Biochem Cell Biol; 2013 Dec; 91(6):361-8. PubMed ID: 24219277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Regulation of Chromatin in Prostate Cancer.
    Natesan R; Aras S; Effron SS; Asangani IA
    Adv Exp Med Biol; 2019; 1210():379-407. PubMed ID: 31900918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.